Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.5692
+0.0232 (4.25%)
Aug 15, 2025, 10:27 AM - Market open
Rallybio Market Cap
Rallybio has a market cap or net worth of $23.78 million as of August 15, 2025. Its market cap has decreased by -56.53% in one year.
Market Cap
23.78M
Enterprise Value
-22.88M
1-Year Change
-56.53%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $23.78M, a decrease of -94.14%. That is a compound annual growth rate of -50.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 22.37M | -43.83% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | 405.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 587.60B |
| Johnson & Johnson | 417.89B |
| AbbVie | 354.85B |
| UnitedHealth Group | 245.37B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 224.62B |
| Novo Nordisk | 223.00B |